To confirm whether DNAJB1 can be used as a novel biomarker in the plasma, the plasma exosomal RNA-Seq data of 6 healthy donors and 14 patients with pancreatic carcinoma from the GSE106804 (40) and GSE100232 (41) datasets were downloaded and integrated. This evidence concerns the gene DNAJB1 and exocrine pancreatic carcinoma.